Articles from BIOTECH Patent News (July 1, 1998)

1-62 out of 62 article(s)

Title	Type	Words
Abgenix and Millennium BioTherapeutics form collaboration	Article	434
AlphaOne Pharmaceuticals announces issuance of alpha 1-antitrypsin patent for use in respiratory distress syndrome	Article	401
Anergen awarded fundamental patent for technology for autoimmune disease treatment	Article	296
Applied Immune Sciences obtains United States patent		18
Biocatalyst separation process patent issues to Energy BioSystems	Article	347
Boehringer Mannheim obtains United States patent		35
Chiron obtains United States patent		21
Cytoclonal Pharmaceutics issued lung cancer marker patent by United States Patent and Trademark Office	Article	244
DEKALB Genetics granted patent for method of increasing water stress tolerance in plants	Article	274
DEKALB Genetics granted patent for novel selectable marker technology for corn transformation	Article	151
Desmos obtains United States patent		32
Diacrin and Massachusetts General Hospital rReceive United States patent for immune system 'masking' technology	Article	350
Dutch court upholds Immunomedics' patent	Article	386
Eli Lilly obtains United States patent		24
Embrex applies for patent		41
Fox Chase Cancer Center obtains United States patent		42
Genentech applies for patent	Article	43
Genentech obtains United States patent		19
Glaxo Wellcome obtains United States patent		23
Harvard applies for patent		46
Health Research obtains United States patent		26
Heska obtains United States patent		28
Human Genome Science applies for patent		41
IDEC obtains United States patent		22
ImaRx receives patent for targeted drug delivery	Article	222
Immunex and American Home Products restructure research and license agreements	Article	518
Incyte applies for patent	Article	40
Innovir obtains United States patent		56
Institut Pasteur obtains United States patent		38
ISIS obtains United States patent		23
Janssen and Sepracor announce Propulsid metabolite licensing agreement	Article	301
Life Medical Science obtains United States patent		24
Liposome applies for patent		39
LXR Biotechnology obtains United States patent		41
Mayo Foundation obtains United States patent		32
Medical Reserach Council applies for patent		33
Medical Sciences Research obtains United States patent		39
Merck applies for patent		38
Millennium applies for patent		41
Mount Sinai Hospital obtains United States patent		37
Oklahoma Medical Research Foundation obtains United States patent		41
OraVax receives United States patent for the use of a protein to detect highly virulent strains of Helicobacter pylori	Article	345
Paracelsian patents approved for HIV treatment and cancer screen	Article	752
PathoGenesis receives United States patent for aerosolized drug candidate	Article	436
Plant Genetic Systems obtains United States patent		36
Sagami obtains United States patent		33
Smithkline obtains United States patent		28
Spectral Diagnostics reports court declined to issue a preliminary injunction but is committed to an August 31, 1998 trial regarding an alleged infringement of United States Patent 5,744,358 by Biosite Diagnostics	Article	160
T Cell Sciences receives three United States patent allowances for its lead complement inhibitor	Article	416
Teijin obtains United States patent		69
Thomas Jefferson University applies for patent		40
United Biomedical obtains United States patent	Article	38
United States Judge grants Biochem's motion to say 3TC patent case	Article	201
University of California obtains United States patent		20
University of Minnesota applies for patent		45
University of North Carolina applies for patent		40
University of Wales College of Medicine obtains United States patent		41
Variagenics receives four United States pharmacogenomics patents covering methods for high throughput genetic variance discovery	Article	585
Vascular Therapeutics awarded three United States patents for its lead drug Vasoflux	Article	193
Wellesley College applies for patent		49
Wistar Institute obtains United States patent		37
Zymogenetics applies for patent		40